EMEA-002202-PIP01-17

Key facts

Active substance
  • Rosuvastatin
  • Ezetimibe
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0335/2017
PIP number
EMEA-002202-PIP01-17
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of hypercholesterolaemia
Route(s) of administration
Oral use
Contact for public enquiries
Krka, d.d., Novo mesto
Tel. +38 67331 2055
E-mail: tomaz.kralj@krka.biz
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating